Housing Watch Web Search

Search results

1. Results From The WOW.Com Content Network

2. What are the drugs affected by Medicare deal to lower costs?

   www.aol.com/news/know-medicare-negotiation...

   Eliquis prevents and treats blood clots. The negotiated price is $23, down 56%. ... Medicare is a federal health insurance program for Americans who are 65 years of age or older. Some individuals ...

3. Biden administration says Medicare negotiated price discounts ...

   www.aol.com/news/biden-administration-says...

   The list price of Merck's diabetes drug Januvia will be slashed to $113 for a 30-day supply from $527 as of 2023. Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer, will cost $231 for ...

4. Biden admin announces results of historic Medicare drug price ...

   www.aol.com/medicare-enrollees-save-billions...

   Medicare’s new power to negotiate drug prices will lead to an estimated $6 billion in savings for the federal government and a $1.5 billion reduction in out-of-pocket costs for seniors when the ...

5. Medicare to save $6B in 2026 from the first ever Part D ... - AOL

   www.aol.com/finance/medicare-save-6b-2026-first...

   The same year Bristol Myers Squibb earnings data showed $11.8 billion in sales for Eliquis, and Pfizer, which co-markets the drug, reported $6.5 billion in sales — a combined $17.3 billion.

6. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban. Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [ 6][ 7][ 8] Specifically, it is used to prevent blood clots following hip or knee replacement and in those with a ...

7. Factbox-Top Medicare drugs headed for price cuts - AOL

   www.aol.com/news/factbox-top-medicare-drugs...

   Jardiance. Boehringer Ingelheim and Eli Lilly's Jardiance is used to treat type-2 diabetes, heart failure and chronic kidney disease. It cost Medicare $7 billion for 1.6 million patients in the ...

8. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Discovery and development of direct Xa inhibitors. Four drugs from the class of direct Xa inhibitors are marketed worldwide. Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States ...

9. First-Time Negotiations Have Lowered Prices On 10 Expensive ...

   www.aol.com/biden-announce-drug-price-agreements...

   August 15, 2024 at 12:25 PM. The first-ever negotiations between the federal government and pharmaceutical companies have led to agreements that will lower the prices of 10 treatments, reducing ...